Biosfer Teslab in the 8th National Cardiovascular Meeting of SEMERGEN
On the 21th of May, Biosfer Teslab took part in the 8th Cardiovascular Meeting of SEMERGEN, in Santander. Nuria Amigó took part in a session which name was “The significance…
News
Discover the most recent news about our company
The Di@bet.es 2 study will define risk scales that will let us apply prevention programs for less people, but better targeted
The Research Program of CIBERDEM is focused on the study of the epidemiology of diabetes mellitus; genetics, epigenetics and related environmental factors with this pathology, and the associated molecular mechanisms…
Prize-giving for young talents
Biosfer Teslab was awarded with one of the Premis Gresol for Young talents in front of 250 people at Flash Back room, Salou, from the Gresol Fundation. These prizes reclaim…
Biosfer Teslab to Boston
Biosfer to Boston, one of the 20 finalists projects of the international startups acceleration program, The Big Booster More information here.
Biosfer Teslab in the newspaper la Vanguardia
News about Biosfer Teslab appeared in the reportage of the la Vanguardia newspaper, 25 of October, 2015, it’s title was “Un test més efectiu per al ‘colesterol dolent'” that means…
Open call to join our operations team
Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for candidates to join our…
Open call for an Industrial Doctorate
Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for Industrial Doctorate candidates. The…
Practical Applications of NMR in Industry Conference (PANIC) – Feb 2015 La Jolla, CA
Roger Mallol will give a talk in the 3rd Annual Practical Applications of NMR in Industry Conference (PANIC) that will take place in La Jolla, CA, February 9-12, 2015. PANIC…
Call for an Industrial Doctoral Student
Biosfer Teslab is seeking candidates for an industrial doctorate to develop NMR-based in vitro diagnostic tests for cardiovascular risk assessment. Further information about the call can be found here.
